O02.0
Blighted ovum and nonhydatidiform mole
Clinical Classification Guidelines
Inclusion Terms
- Carneous mole
- Fleshy mole
- Intrauterine mole NOS
- Molar pregnancy NEC
- Pathological ovum
Medical Intelligence & Overview
The terms 'blighted ovum' and 'nonhydatidiform mole' refer to conditions affecting early pregnancy, characterized by abnormal development of the embryo or placental tissue. These issues often lead to pregnancy loss but are important for understanding early reproductive health. A blighted ovum occurs when a fertilized egg implants in the uterus but the embryo fails to develop, while a nonhydatidiform mole involves abnormal growth of placental tissue without a developing fetus. Recognized under ICD-10 code O02.0, these conditions can sometimes be associated with molar pregnancies, which involve abnormal trophoblastic growth within the uterus.
Causes & Symptoms
Clinical Causes: Chromosomal abnormalities in the fertilized egg Genetic factors influencing embryonic development Maternal health issues such as hormonal imbalances Uterine abnormalities or structural issues Environmental exposures or radiation Infections during conception or early pregnancy
Key Symptoms: Vaginal bleeding or spotting Lower abdominal cramping or pain Absence of fetal heartbeat on ultrasound Expired pregnancy symptoms such as nausea or breast tenderness diminish Pelvic pressure or fullness
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves ultrasound examinations, which reveal a gestational sac without an embryo in the case of a blighted ovum. Blood tests measuring levels of human chorionic gonadotropin (hCG) can support diagnosis, showing abnormal or declining hormone levels. In some instances, a dilation and curettage (D&C) procedure may be performed to remove pregnancy tissue and confirm diagnosis. Further supportive tests might include genetic analysis to examine potential chromosomal causes or uterine evaluations if structural abnormalities are suspected.
Treatment Protocols: Treatment options depend on individual circumstances and may include: - Expectant management: allowing the body to naturally expel pregnancy tissue - Medical management: use of medications such as misoprostol to induce uterine contractions - Surgical management: dilation and curettage (D&C) to remove remaining tissue Follow-up care involves monitoring hormone levels until they return to pre-pregnancy levels to ensure complete resolution. Emotional support and counseling are often recommended due to the emotional impact of pregnancy loss. In cases of molar pregnancy, additional follow-up may involve blood tests to detect rare complications such as gestational trophoblastic disease.
Clinical Advice & FAQs
Billing Guidance
Is O02.0 a billable ICD-10 code?
Yes, O02.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O02.0?
Clinical documentation must specify the nature of Blighted ovum and nonhydatidiform mole and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
